Brainstorm Cell Therapeutics, Inc. (BCLI)
0.90
-0.08
(-8.16%)
USD |
OTCM |
Sep 18, 16:00
Brainstorm Cell Therapeutics Total Return Price : 0.90 for Sept. 18, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| September 18, 2026 | 0.90 |
| September 17, 2026 | 0.98 |
| September 16, 2026 | 0.979 |
| September 15, 2026 | 1.04 |
| September 14, 2026 | 1.063 |
| September 11, 2026 | 1.08 |
| September 10, 2026 | 1.03 |
| September 09, 2026 | 1.00 |
| September 08, 2026 | 0.99 |
| September 04, 2026 | 1.05 |
| September 03, 2026 | 1.07 |
| September 02, 2026 | 1.25 |
| September 01, 2026 | 1.168 |
| August 31, 2026 | 1.065 |
| August 28, 2026 | 1.123 |
| August 27, 2026 | 1.163 |
| August 26, 2026 | 1.20 |
| August 25, 2026 | 1.00 |
| August 24, 2026 | 1.00 |
| August 21, 2026 | 0.98 |
| August 20, 2026 | 1.06 |
| August 19, 2026 | 1.218 |
| August 18, 2026 | 1.41 |
| August 17, 2026 | 1.085 |
| August 14, 2026 | 0.99 |
| Date | Value |
|---|---|
| August 13, 2026 | 0.816 |
| August 12, 2026 | 0.8675 |
| August 11, 2026 | 0.85 |
| August 10, 2026 | 0.79 |
| August 07, 2026 | 0.7875 |
| August 06, 2026 | 0.80 |
| August 05, 2026 | 0.7759 |
| August 04, 2026 | 0.7725 |
| August 03, 2026 | 0.79 |
| July 31, 2026 | 0.90 |
| July 30, 2026 | 0.918 |
| July 29, 2026 | 0.8956 |
| July 28, 2026 | 0.92 |
| July 27, 2026 | 0.934 |
| July 24, 2026 | 0.96 |
| July 23, 2026 | 1.00 |
| July 22, 2026 | 0.98 |
| July 21, 2026 | 0.92 |
| July 20, 2026 | 0.95 |
| July 17, 2026 | 0.8962 |
| July 16, 2026 | 0.9425 |
| July 15, 2026 | 0.9727 |
| July 14, 2026 | 0.96 |
| July 13, 2026 | 1.046 |
| July 10, 2026 | 1.08 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| NovelStem International Corp. | 0.0095 |
| Summit Therapeutics, Inc. | 16.91 |
| Kezar Life Sciences, Inc. | 7.29 |
| Protara Therapeutics, Inc. | 3.51 |
| Clene, Inc. | 4.555 |